Sexually Transmitted Infections
Portfolio of sexually transmitted infection tests designed to maximise use of standard laboratory equipment and provide clinically relevant and actionable information for improved patient management.
Sexually Transmitted Infections
Utilize SpeeDx assays to detect pathogens known to cause sexually transmitted infections. Our tests are cost-effective and designed to maximise use of standard laboratory equipment.
Research Use Only
Antibiotic resistance in sexually transmitted infections (STIs) is a growing public health issue due to the misuse and overuse of antibiotics. STIs have the potential to become the first incurable bacterial infections since the introduction of antibiotics. Diagnostic tests that detect bacterial infection and genetic markers for antibiotic resistance in a single test can address this looming issue by enabling Resistance Guided Therapy.[1-4]
“SpeeDx is uniquely positioned in the sexual health diagnostics space, with technology and tests that can inform treatment decisions. We are excited about the impact they are having now, in Europe and Australian markets, and we look forward to what we can achieve together with the current investors as we [expand further into the U.S.]”
Michael P. Rubin, M.D., Ph.D. Northpond Ventures founder and CEO